PURPOSE. We evaluated the roles of tumor necrosis factor (TNF)-a in alkali-induced corneal neovascularization (CNV).
METHODS. CNV was induced by alkali injury and compared in wild-type (WT) BALB/c mice, and TNF receptor 1-deficient (TNF-Rp55 KO) counterparts, or in mice treated with TNF-a antagonist and recombinant TNF-a. Angiogenic factor expression and leukocyte accumulation in the early phase after injury were quantified by real-time PCR and immunohistochemical analysis, respectively.
RESULTS.
Alkali injury augmented the intraocular mRNA expression of TNF-a and its receptor, together with a transient macrophage and neutrophil infiltration. Compared to WT mice, TNF-Rp55 KO mice exhibited reduced CNV. Intraocular F4/80-positive macrophages and Ly-6G-positive neutrophils infiltration did not change in KO mice compared to WT mice after the injury. Alkali injury induced a massively increased intraocular mRNA expression of angiogenic factors, including vascular endothelial growth factor (VEGF), inducible nitric oxide synthase (iNOS), interleukin (IL)-6, E-selectin, and intercellular adhesion molecule (ICAM)-1 in WT mice, whereas these increments were retarded severely in KO mice. Immunofluorescence analysis demonstrated that F4/80-positive cells expressed VEGF and iNOS. Moreover, TNF-a enhanced VEGF and iNOS expression by peritoneal macrophage from WT, but not KO mice. Topical application of TNF-a antagonist reduced CNV, while topical application of recombinant TNF-a enhanced it.
CONCLUSIONS. TNF-Rp55-KO mice exhibited impaired alkaliinduced CNV through reduced intracorneal infiltrating macrophage VEGF and iNOS expression. (Invest Ophthalmol Vis Sci. 2012;53:3516-3526) DOI:10.1167/iovs. T he cornea is characterized by an absence of blood vessels under physiological conditions. 1 Corneal avascularity is essential to visual acuity, and depends on the balance between angiogenic and anti-angiogenic molecules. [2] [3] [4] [5] [6] Corneal neovascularization (CNV) arises from various causes, including corneal infections, misuse of contact lenses, chemical burns, and inflammation, [7] [8] [9] and frequently can lead to impaired vision. Before the onset of CNV, a large number of neutrophils and, to a lesser degree, monocytes/macrophages infiltrate into the cornea. We proved previously that experimental CNV can occur independently of granulocyte infiltration. 10 Moreover, we observed that infiltrated macrophages exert complicated roles, by using different chemokine receptor signals in the development of CNV. [11] [12] [13] A proinflammatory cytokine, tumor necrosis factor-a (TNFa), is produced by a variety of cell types, including neutrophils, macrophages, lymphocytes, and endothelial cells. 14 TNF signals through two distinct cell surface receptors, TNF-receptor (TNF-R)p55, and TNF-Rp75. TNF-Rp55 mediates the major biological activities of TNF-a. 15 Based on their essential roles in inflammatory responses, anti-TNF-a mAbs or TNF antagonists have been used to treat inflammatory ocular diseases and uveitis. 16 Although evidence is accumulating to indicate the essential roles of the TNF-a-TNF-Rp55 axis in inflammatory responses, the involvement of this axis in angiogenesis is defined poorly. Saika et al. observed that alkali-induced CNV was more severe in TNF-a-deficient mice than wild-type (WT) controls. 17 They demonstrated further that endogenous TNF-a can counteract the activities of transforming growth factor (TGF)-b and vascular endothelial growth factor (VEGF) on vascular endothelial cells, thereby inhibiting corneal neovascularization. 18 On the contrary, TNF-a can induce endothelial cell migration in vitro and angiogenesis in vivo, when implanted into corneas, chorioallantoic membranes, or sponge implants. [19] [20] [21] [22] In line with these observations, Shi et al. reported that a TNF antagonist, etanercept, and TNF antibody reduced laserinduced choroidal neovascularization. 23 An anti-TNF mAb, infliximab, was reported to be effective against age-related macular degeneration (AMD), 24 which is characterized by choroidal neovascularization. These conflicting observations prompted us to investigate further the roles of TNF-a on ocular neovascularization, by using a frequently used ocular neovascularization model, alkali injury-induced CNV.
MATERIALS AND METHODS

Reagents and Antibodies
A specific TNF antagonist, etanercept, was purchased from Wyeth Pharmaceutical (Osaka, Japan). Recombinant mouse interferon (IFN)-c (catalog No. 485-MI/CF) and mouse VEGF ELISA Kit (MMV00) were obtained from R&D Systems (Minneapolis, MN). Rat anti-mouse F4/80 (clone A3-1) mAb was acquired from Serotec (Oxford, UK). Rat antimouse CD31 (MEC13.3), anti-mouse-Ly-6G (Clone IA8, catalog No. 551495) mAbs, and rabbit anti-inducible nitric oxide synthase (iNOS) (catalog No. 610332) polyclonal antibodies, were purchased from BD Pharmingen (San Diego, CA). Rabbit anti-mouse TNF-a (ab34674) and anti-mouse TNF-Rp55 (ab19139) polyclonal antibodies were supplied by Abcam (Cambridge, UK). Goat anti-mouse VEGF (sc-1836) polyclonal antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). VECTASHIELD Mounting medium with DAPI (H-1200) was obtained from Vector Laboratories (Burlingame, CA). Recombinant mouse TNF-a and IL-1b, and neutralizing rabbit anti-mouse TNF-a IgG were prepared as described previously. 25 
Mice
Pathogen-free BALB/c mice were obtained from Clea Japan (Yokohama, Japan), and were designated as WT mice in the present experiments. TNF-Rp55-deficient mice were backcrossed to BALB/c mice from eight to 10 generations, 26, 27 and bred under specific pathogen-free conditions at the Animal Research Center of Kanazawa University (Kanazawa, Japan). Seven-to 8-week-old male mice were used for the experiments. All animal experiments were performed under specific pathogen-free conditions in the Institute for Experimental Animals, Kanazawa University, in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, and complied with the standards set out in the Guidelines for the Care and Use of Laboratory Animals of Kanazawa University.
Alkali-Induced Corneal Injury Model
Corneal injury was induced by placing a 2-mm filter disc saturated with 1 N NaOH onto the left eye of the mouse for 45 seconds as described previously. [10] [11] [12] [13] TNF-a, etanercept, and anti-TNF-a antibodies were dissolved in 0.2% sodium hyaluronate (Sigma-Aldrich) immediately before the topical application. In some experiments, the alkali-treated eyes received 5 lL of TNF-a antagonist preparation dissolved in 0.2% sodium hyaluronate at a concentration of 0.5 or 1 mg/mL, or 5 lL of 0.2% sodium hyaluronate as vehicle twice a day for 7 days immediately after the alkali injury. In another series of experiments, the eyes were treated with alkali for 40 seconds, and received 5 lL of recombinant mouse TNF-a preparation or neutralizing rabbit anti-mouse TNF-a IgG at a concentration of 100 lg/mL, or 5 lL of 0.2% sodium hyaluronate as vehicle twice a day for 7 days immediately after the alkali injury. At the indicated time intervals, mice were sacrificed and whole eyes were removed. The eyes were snap-frozen in ornithine carbamoyltransferase (OCT) compound for histological analysis, or the corneas were removed and placed immediately into RNALate (Qiagen, Tokyo, Japan) and kept at À868C until total RNA extraction was performed. Each experiment was repeated at least three times.
Histological and Immunohistochemical Analysis
The OCT-embedded tissues were cut into 8-lm thick slices, and the fixed cryosections then were subjected to hematoxylin and eosin staining. The sections were incubated overnight at 48C with rat antimouse F4/80 antibody (1 lg/mL) and rat anti-mouse-Ly-6G (2.5 lg/mL) to identify macrophages and neutrophils, respectively. Tissue sections then were incubated with biotin-conjugated anti-rat immunoglobulin antibodies as secondary antibodies. Other sets of sections were incubated overnight at 48C with rabbit anti-TNF-a, rabbit anti-TNFRp55, and goat anti-VEGF pAbs, to detect TNF-a, TNF-Rp55, and VEGF expression, respectively. These slides were incubated with biotinconjugated anti-rabbit or anti-goat immunoglobulin antibodies as the secondary antibodies. The immune complexes were detected by using an ABC kit and a DAB Substrate Kit from Vector Laboratories, Inc. according to the manufacturer's instructions. Slides then were counterstained with hematoxylin and mounted. The numbers of F4/ 80-or Ly-6G-positive cells were counted at 200-fold magnification in five randomly chosen fields of corneal sections from each animal, [11] [12] [13] by an examiner with no prior knowledge of the experimental procedures. The numbers of positive cells per mm 2 were calculated.
A Double-Color Immunofluorescence Analysis
A double-color immunofluorescence analysis was performed to determine VEGF or iNOS expression by infiltrating macrophages. Briefly, the fixed cryosections (8 lm thick) were incubated with PBS containing 10% normal donkey serum and 1% BSA to reduce nonspecific reactions. Thereafter, the sections were incubated with the combinations of rat anti-Ly-6G and goat anti-VEGF, rat anti-F4/80 and goat anti-VEGF, rat anti-F4/80 and rabbit anti-iNOS, or rabbit anti-TNF-a and goat anti-VEGF Abs overnight at 48C. After being rinsed with PBS, for a double-immunofluorescence analysis using anti-VEGF, the sections then were incubated with a combination of Alexa Fluor 594 donkey anti-rat IgG and Alexa Fluor 488 donkey anti-goat IgG (1/100) for 45 minutes at room temperature in the dark. For doubleimmunofluorescence analyses to detect macrophage iNOS expression, the sections were incubated further with the combination of Alexa Fluor 594 donkey anti-rat IgG and Alexa Fluor 488 donkey anti-rabbit IgG (1/100) for 45 minutes at room temperature in the dark. For double-immunofluorescence analyses using anti-TNF-a and anti-VEGF, the sections were incubated further with the combination of Alexa Fluor 594 donkey anti-rabbit IgG and Alexa Fluor 488 donkey anti-goat IgG (1/100) for 45 minutes at room temperature in the dark. Finally, the sections were washed with PBS and mounted with VECTASHIELD Mounting medium with DAPI, and immunofluorescence was visualized with a fluorescence microscope (Olympus, Tokyo, Japan). Images were processed by using graphics software (Adobe Photoshop, version 7.0; Adobe, Mountain View, CA).
Enumeration of Corneal Neovascularization
Corneal whole mount staining was performed and blood vessels in the corneas were measured according to previous reports. 2, 28 Corneal flat mounts were rinsed in PBS, fixed in acetone, rinsed in PBS, blocked in 2% BSA, stained with rat anti-mouse CD31 (1:100; BD Pharmingen) at 48C overnight, and washed, and the corneas then were incubated with Alexa Fluor 594 or Alexa Fluor 488 donkey anti-rat IgG (1/100) for 2 hours at room temperature in the dark and analyzed by microscope. Digital pictures of the flat mounts were taken. Then, the area covered by CD31 was measured morphometrically on these flat mounts using NIH Image software (National Institutes of Health, Bethesda, MD). The total corneal area was outlined using the innermost vessel of the limbal arcade as the border. The total area of neovascularization then was normalized to the total corneal area, and the percentage of the cornea covered by vessels calculated. In another series of experiments, the fixed cryosections (8 lm thick) were stained with rat anti-mouse CD31 (1:100; BD Pharmingen) at 48C overnight, washed, and then incubated with biotin-conjugated anti-rat immunoglobulin antibody as secondary antibodies. The immune complexes were detected by using an ABC kit and a DAB Substrate Kit from Vector Laboratories, Inc. according to the manufacturer's instructions. Slides then were counterstained with hematoxylin and mounted. The numbers and sizes of the CNV were determined as described previously, [11] [12] [13] by an examiner with no knowledge of the experimental procedures. Briefly, images were captured with a digital camera and imported into Adobe Photoshop. Then, the numbers of neovascular tubes per mm 2 , and the proportions of CNV in the hot spots were determined using NIH Image analysis software. [11] [12] [13] Most sections were taken from the central region of the cornea. The numbers and areas of corneal neovascularization were evaluated on at least two sections from each eye.
RNA Isolation and Real-Time PCR
Total RNAs were extracted from the corneas or cultured macrophages with the use of RNeasy Mini Kit (Qiagen). The resultant RNA preparations were treated further with ribonuclease-free deoxyribonuclease (DNase) I (Life Technologies Inc., Gaithersburg, MD) to remove genomic DNA. The PCR solution contained 2 lL cDNA, the specific primer set (0.2 lM final concentration), and 12.5 lL of SYBR Premix Ex Taq TM (SYBR Premix Ex Taq Perfect Real Time PCR Kit; Takara) in a final volume of 25 lL. The sequences of the PCR primer pairs are listed in the Table. Quantitative PCR was performed on iCycler iQ Multi-Color Real Time PCR Detection System (170-8740; Bio-Rad, Shanghai, China). PCR parameters were initial denaturation at 958C for 1 minute, followed by 40 circles of 958C for 5 seconds, and 608C for 30 seconds. mRNA expression was normalized to the levels of b-actin mRNA.
Isolation and Culture of Murine Peritoneal Macrophages
Peritoneal macrophages from WT or TNF-Rp55 KO mice were obtained as described previously. 11, 12 The cells were suspended in antibiotic-free RPMI medium containing 10% fetal bovine serum (FBS), and incubated in a humidified incubator at 378C in 5% CO 2 in 6-well cell culture plates (Nalge Nunc International Corp., Naperville, IL). Two hours later, nonadherent cells were removed, and the medium was replaced. The cells then were stimulated with the indicated concentrations of murine TNF-FIGURE 1. The expression of TNF-a and its receptor, TNF-Rp55, in cornea after alkali injury. Real-time PCR was conducted to detect TNF-a (A) and TNF-Rp55 (B) mRNA normalized to the levels of b-actin mRNA as described in Materials and Methods, and are shown with mean 6 SEM. Representative results from 3 independent experiments are shown. *P < 0.05; **P < 0.01 vs. D0. (C) Whole eyes were obtained at 0, 2, 4, and 7 days after alkali injury, and processed for immunohistochemical analysis using anti-TNF-a (upper panels) and anti-TNF-Rp55 (lower panels) antibodies. Representative results from 3-5 animals of each time point are shown. Arrows indicate the positive cells. Original magnification ·400. Scale bar 50 lm. 
F, forward primer; R, reverse primer.
a for 12 hours or the indicated concentrations of LPS, IFN-c or IL-1b for 24 hours. Total RNAs were extracted from the cultured cells and subjected to real-time PCR as described above. In another series of experiments, murine macrophages were seeded onto 12-well-plates at 5 · 10 5 cells/well. After adhesion, the cells were stimulated with the indicated concentrations of murine TNF-a for 12 hours in a 378C incubator with 5% CO 2. Supernatants were collected to determine VEGF concentrations using a Mouse VEGF ELISA Kit (R&D Systems), according to the manufacturer's instructions.
Statistical Analysis
The means and SEM were calculated for all parameters determined in the study. Data were analyzed statistically using one-way ANOVA, or two-tailed Student's t-test. A value of P < 0.05 was considered statistically significant.
RESULTS
Intracorneal Expression of TNF-a, and its Receptor, TNF-Rp55 after Alkali-Induced Corneal Injury
We first examined the expression of TNF-a and its receptor, TNF-Rp55, in corneas after alkali-induced corneal injury. TNF-a mRNA barely was detectable in untreated eyes, but was increased markedly after alkali injury (Fig. 1A) . Concomitantly, TNF-a protein was detected immunohistochemically in infiltrating cells after alkali injury, but not in untreated eyes (Fig.  1C, upper panels) . Moreover, alkali injury augmented markedly the mRNA expression of TNF-Rp55 (Fig. 1B) . Furthermore, immunohistochemical analysis demonstrated that the infiltrated leukocytes and corneal epithelial cells expressed TNF-Rp55 (Fig. 1C, lower panels) . The enhanced intracorneal expression of TNF-a and TNF-Rp55 suggests the possible involvement of the TNF-a-TNF-Rp55 interactions in alkali-induced CNV.
Impaired Alkali-Induced CNV in TNF-Rp55 KO Mice
We next explored the effects of genetic ablation of TNF-Rp55 on alkali-induced CNV. CNV was evident macroscopically in WT mice 2 weeks after the injury, consistent with our previous reports. 11 -13 CNV at 2 weeks after the injury was attenuated significantly in TNF-Rp55 KO mice compared to those of WT mice as evidenced by corneal whole mount method (Figs. 2A,  2B ). Immunohistochemical analysis using anti-CD31 antibodies revealed similar tendencies in WT and TNF-Rp55 KO mice even at microscopic levels (Figs. 2C, 2D ). These observations indicate that the TNF-a-TNF-Rp55 axis was indispensable for alkali-induced CNV. 
Marginal Effects of TNF-Rp55 Deficiency on Alkali Injury-Induced Intraocular Leukocyte Infiltration
We observed previously that Ly-6G-positive granulocytes and F4/80-positive macrophages infiltrated injured corneas, reaching their peak levels 2 and 4 days after the injury in WT mice, respectively. [11] [12] [13] Monocytes/macrophages can be a rich source of angiogenic factors, [29] [30] [31] [32] [33] while infiltrated granulocytes have few roles in alkali-induced CNV. 10 Hence, we examined the effects of TNF-Rp55 deficiency on macrophage and granulocyte infiltration into the wounded corneas. Rare F4/ 80-positive macrophages were observed in untreated corneas as observed previously.
11 Ly-6G-positive granulocytes (data not shown) and F4/80-positive macrophages infiltrated into corneas to similar extents in WT mice compared to TNFRp55 KO mice after the injury (Fig. 3) . We observed further that mRNA of a major macrophage-tropic chemokine, CCL2, was enhanced in corneas of WT and TNF-Rp55 KO mice to similar extents after alkali injury (Fig. 3C) . Thus, the lack of TNF-Rp55 has few apparent effects on the intraocular infiltration of leukocytes in the present alkali injury-induced CNV, probably because it has few effects on the expression of a potent macrophage-tropic chemokine, CCL2.
Reduced Pro-Angiogenic and Adhesion Molecule Expression in TNF-Rp55 KO Mice after Alkali Injury
The balance between angiogenic and anti-angiogenic factors determines the outcome of angiogenesis processes in various situations. Hence, we examined the mRNA expression of angiogenic and anti-angiogenic factors in corneas after alkali injury. Alkali injury increased intraocular mRNA expression of an angiogenic factor, TGF-b, and an anti-angiogenic molecule, thrombospondin (TSP)-1 in WT and TNF-Rp55 KO mice to similar extents (Fig. 4) . After alkali injury, WT mice exhibited augmented intraocular mRNA expression of other potent angiogenic molecules, including VEGF, basic fibroblast growth factor (bFGF), iNOS, interleukin (IL)-6, and adhesion molecules, E-selectin and intercellular adhesion molecule (ICAM)-1, and the enhanced expression of these molecules was attenuated markedly in TNF-Rp55 KO mice (Fig. 4) . On the contrary, the expression of IL-1a and IL-1b was enhanced to similar extents in WT and KO mice. Consistently with our previous observations, 10 immunohistochemical analysis demonstrated that infiltrating leukocytes and repopulating epithelial cells after alkali injury expressed VEGF in the early phase (Fig. 5A) . A double immunofluorescence analysis demonstrated that infiltrating macrophages (Fig. 5B) , but not the Ly-6G-positive granulocytes, mainly expressed VEGF. Moreover, double-color immunofluorescence analysis detected the cells expressing simultaneously VEGF and TNF-a (Fig. 5B) , indicating that the infiltrating macrophages expressed VEGF and TNFa. We further revealed that F4/80-positive macrophage also expressed iNOS (Fig. 5B) . Thus, intraocularly infiltrated macrophages expressed VEGF and iNOS, two potent angiogenic molecules.
Enhanced VEGF and iNOS Expression by Murine Macrophages with TNF-a Stimulation
We observed that alkali injury enhanced intracorneal TNF-a mRNA expression to similar extents in WT and TNF-Rp55 KO mice (Fig. 4) . Hence, we next examined the effects of TNF-a on the expression of VEGF and iNOS. TNF-a enhanced markedly the mRNA expression of VEGF and iNOS by peritoneal macrophages from WT mice in a dose-dependent manner (Figs. 6A, 6B) . Moreover, TNF-a augmented VEGF protein production by macrophages (Fig. 6C) , but TNF-Rp55 deficiency abrogated the responsiveness of macrophages to TNF-a in terms of VEGF and iNOS expression (Figs. 6A-C) . Moreover, the intracorneal numbers of VEGF and F4/80 double-positive macrophages were reduced in TNF-Rp55 KO mice compared to WT mice after injury (Fig. 5B) . However, LPS, IFN-c, or IL-1b induced WT-or TNF-Rp55 KO-derived macrophages to express VEGF or bFGF to similar extents (Figs. 6D-F) , indicating that TNF-Rp55 deficiency did not impair the capacity of macrophages to express VEGF or bFGF as a whole. These observations would indicate that TNF-a can induce macrophages to express potent angiogenic molecules, VEGF, iNOS, and bFGF, solely through the interaction with TNF-Rp55.
Effects of TNF-a and its Inhibitors on AlkaliInduced CNV
The genetic deletion of TNF-Rp55 gene may have compound effects on the phenotypes observed after alkali injury. To exclude this possibility, we first examined the effects of topical application of TNF-a antagonist, etanercept, on alkali-induced CNV of WT mice. Etanercept reduced alkali-induced CNV level compared to control mice (Fig. 7) . Because etanercept is a fusion protein between the extracellular portion of human TNF-Rp75 and human IgG Fc portion, it can block TNF-a and TNF-b. 16 To clarify the roles of TNF-a more definitively, we next examined the effects of recombinant mouse TNF-a or neutralizing anti-mouse TNF-a topical application on alkaliinduced CNV of WT mice. Topical administration of mouse recombinant TNF-a enhanced alkali-induced CNV when it was administered locally in the early phase after alkali injury at the concentration of 100 lg/mL (Fig. 8) . Neutralizing anti-mouse TNF-a consistently attenuated alkali-induced CNV when given topically in the early phase after alkali injury (Fig. 8) . These observations indicate further that TNF-a may promote alkaliinduced CNV by activating the infiltrated macrophages to produce potent angiogenic factors, VEGF and iNOS.
DISCUSSION
TNF-a is a proinflammatory cytokine produced by a variety of cell types including neutrophils, macrophages, lymphocytes, and endothelial cells.
14 There are two distinct types of TNF receptors, TNF-Rp55 and TNF-Rp75. TNF-Rp55 is expressed ubiquitously by most types of cells, whereas TNF-Rp75 usually is restricted to some cell types and its expression should be induced. 16 Thus, most of its biologic activities are mediated by TNF-Rp55. The roles of TNF-a in neovascularization remain elusive. This cytokine can induce endothelial cell migration in vitro, and angiogenesis in vivo, when implanted into corneas, chorioallantoic membranes, or sponge implants. [19] [20] [21] [22] In contrast, the deficiency of TNF-a gene can aggravate ocular neovascularization after alkali injury or central cauterization. 17, 18 TNF-Rp55 KO mice exhibited no abnormalities in physiologic retinal neovascularization, but showed defects in pathologic retinal neovascularization. 34 We observed that a higher dose of TNF-a (500 lg/mL) did not have any apparent effects on alkali-induced CNV when applied topically (data not shown). Thus, the effects of TNF-a may be dependent on its local concentration, exposure duration, and the type and growth state of the target cells. 35, 36 These discrepancies prompted us to define the roles of the TNF-a-TNF-Rp55 axis in alkali-induced CNV. Here, we demonstrated that genetic ablation of TNF-Rp55 gene, and the administration of TNF antagonist or anti-TNF-a, attenuated alkali-induced CNV. Moreover, in contrast to the effects of a higher dose of TNF-a (500 lg/mL), topical administration of mouse TNF-a (100 lg/mL) aggravated alkali-induced CNV. These results were inconsistent with the previous observation on TNF-a-deficient mice. 17, 18 These discrepancies may be explained by the differences in the mouse strains used in the previous studies 17, 18 and our present work. Moreover, in the previous study, expression of other TNF-related genes, and the effects of TNF antagonists or anti-TNF-a antibodies were not examined. Thus, it cannot be excluded that genetic ablation of TNF-a gene can result in augmentation of TNF-b expression. If so, augmented TNF-b expression can induce neovascularization by acting on TNF-Rp55. On the contrary, if a higher dose of TNF-a might reduce TNF-b expression by a negative feedback mechanism, reduced TNF-b expression might negate the effects of TNF-a.
Normal corneas lack any vasculature, and physiological corneal avascularity is maintained by the net balance between pro-angiogenic and anti-angiogenic factors. [2] [3] [4] [5] [6] Alkali treatment increased the expression of angiogenic factors, VEGF, bFGF, TGFb, IL-6, and iNOS, as well as E-selectin and ICAM-1, the adhesion molecules that have crucial roles in ocular neovascularization. 37, 38 Except TGF-b, the augmented expression of the angiogenic factors and adhesion molecules was depressed in TNF-Rp55-deficient mice compared to WT mice. On the contrary, the expression of a potent anti-angiogenic factor, The representative results from three independent experiments are shown. Each value represents the mean and SEM (n ¼ 3). *P < 0.05; **P < 0.01 compared to untreated. NS, no significant difference for WT versus KO mice. (E) and (F) Real-time PCR results of macrophage VEGF and bFGF expression normalized to the levels of b-actin mRNA after 24 hours of IL-1b (100 ng/mL) stimulation. All values represent means 6 SEM (n ¼ 6 experiments). *P < 0.05, versus untreated WT macrophages; #P < 0.05 versus untreated KO macrophages. TSP-1, was increased to a similar extent in WT and TNF-Rp55 KO mice. Thus, it is likely that TNF-a induced CNV by augmenting the expression of angiogenic factors and adhesion molecules.
Several lines of evidence indicate that macrophages can be pro-angiogenic by producing angiogenic factors in ocular neovascularization. [29] [30] [31] [32] [33] TNF-a and IL-1 can activate similar intracellular signaling pathways, such as NF-jB and AP-1, and can induce the expression of chemokines and adhesion molecules, which are presumed to have crucial roles in the recruitment of leukocytes, including monocytes/macrophages. We recently observed that IL-1ra-deficient mice exhibited enhanced intracorneal macrophage recruitment after alkali injury. 39 Thus, enhanced IL-1 signal can augment macrophage recruitment. Actually, we found that alkali injury increased intraocular IL-1a and IL-1b mRNA expression in WT and TNFRp55 KO mice to similar extents. Moreover, similar observations were obtained on mRNA expression of CCL2, a chemokine crucially involved in macrophage infiltration. We assumed at first that TNF-a may promote neovascularization by inducing macrophage recruitment as we observed in the colon carcinogenesis model. 40 In contrast to our expectation, absence of TNF-Rp55 gene did not reduce alkali injury-induced intracorneal macrophage infiltration, probably due to sustained CCL2 expression. Thus, the TNF-a-TNF-Rp55 interactions did and (D) The CNV area measured by corneal whole mount staining (C), while percent CNV areas in hot spots measured by immunohistochemical staining from corneal cryosections (D) were determined. Each value represents mean and SEM (n ¼ 5 animals). *P < 0.05; **P < 0.01 compared to vehicle. FIGURE 8. The effects of topical TNF-a and anti-TNF-a application on CNV. Neovascularized corneal area of total corneal area percent of WT mice applied topically with TNF-a or anti-TNF-a at 2 weeks after alkali injury measured by whole mount staining. Each value represents mean and SEM. Representative results from 5-7 animals from each group are shown here. *P < 0.05; **P < 0.01 compared to vehicle. Our study demonstrates that TNF-Rp55-KO exhibited impaired alkali-induced corneal neovascularization through reduced expression of VEGF and iNOS by infiltrating macrophages. Anti-TNF therapy may be useful as an angiogenic regulator for treating corneal diseases that exhibit neovascularization.
not have apparent profound effects on the infiltration of macrophages, a rich source of angiogenic factors, in this model.
We observed that intraocularly infiltrated F4/80-positive macrophages expressed two potent angiogenic factors, VEGF and iNOS. Lee et al. reported that TNF-a can stimulate macrophage to express VEGF. 41 Likewise, we observed that TNF-a induced murine peritoneal macrophages from WT, but not TNF-Rp55-deficient mice, to express VEGF and iNOS. Consistently, VEGF expression was depressed in TNF-Rp55 KOderived F4/80-positive macrophages compared to WT-derived ones. Moreover, because we detected TNF-Rp55 mRNA expression in murine peritoneal macrophages (data not shown), these observations would indicate that the TNF-a-TNF-Rp55 axis is crucial to VEGF and iNOS production by TNFRp55-expressing macrophages. However, TNF-Rp55 deficiency failed to abrogate CNV completely, suggesting the contribution of other mediators to CNV. The candidate molecules may be IL1a and IL-1b, because IL-1a and IL-1b can induce the expression of VEGF and bFGF to similar levels in WT and TNF-Rp55 KO-mouse-derived macrophages. This assumption is supported further by the observation that alkali injury enhanced, to similar extents, their intracorneal expression in WT and TNF-Rp55 KO mice.
Double-color immunofluorescence analysis revealed that the infiltrating F4/80-positive macrophages expressed VEGF and TNF-a. M1 macrophages are a main producer of TNF-a, while M2 macrophages can promote angiogenesis by producing VEGF. 42 However, in selected pathological conditions, mixed types of macrophage phenotypes have been observed, 42 particularly in resolution phase of tissue injury. 43 As we conducted double-color immunofluorescence analysis 4 days after the injury, when corneal lesions were in resolution phase, M1-M2 mixed types of macrophages can be detected in the cornea.
Corneal epithelial cell migration also is indispensable to healing after alkali injury by suppressing inflammatory corneal angiogenesis. 28 Okada et al. observed that TNF-a inhibited corneal epithelial cell migration. 44 Thus, decreased TNF-a signal in TNF-Rp55-deficient mice can promote epithelial cell migration, and eventually reduce CNV.
Corneal clarity is necessary for normal vision. Corneal neovascularization frequently can lead to loss of corneal transparency and impaired vision. Our study demonstrates that TNF-Rp55-KO exhibited impaired alkali-induced CNV through reduced expression of VEGF and iNOS by infiltrating macrophages. Moreover, we observed that the treatment with TNF-a antagonist or anti-TNF-a antibodies significantly decreased alkali-induced mouse corneal neovascularization. Thus, anti-TNF therapy may be useful as an angiogenic regulator for treating corneal diseases that exhibit neovascularization. However, this requires further investigation.
